Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting Active Biotech, 9 Sep 2014 Accessed on 23 Sep 2014 from http://www.activebiotech.com/press-releases-1?pressurl=http://cws.huginonline.com/A/1002/PR/201409/1855544.xml. CommentRecommendBookmarkWatch